Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) EBT Margin (2025 - 2026)

BioAge Labs' EBT Margin history spans 1 years, with the latest figure at 835.71% for Q4 2025.

  • On a quarterly basis, EBT Margin changed N/A to 835.71% in Q4 2025 year-over-year; TTM through Dec 2025 was 893.73%, a N/A change, with the full-year FY2025 number at 893.73%, changed N/A from a year prior.
  • EBT Margin hit 835.71% in Q4 2025 for BioAge Labs, up from 979.99% in the prior quarter.
  • Over the last five years, EBT Margin for BIOA hit a ceiling of 835.71% in Q4 2025 and a floor of 979.99% in Q3 2025.